Doxycycline
FAP-Familial Adenomatous Polyposis
michal rollSmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the FAP-Familial Adenomatous Polyposis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Erythromycin michal roll | Phase 4 | BB |
PANITUMUMAB michal roll | Phase 4 | BB |
Same molecule, other indications
Doxycycline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →